VERAPAMIL USE IN CHRONIC HYPERTENSION PREGNANT WOMEN: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/54jdyg68Keywords:
Verapamil, Chronic Hypertension, PregnancyAbstract
Background: Verapamil is a medication that has been approved for the treatment of high blood pressure, abnormal heart rhythm, or angina (chest discomfort or shortness of breath).
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and MetaAnalysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2013 and 2023 were taken into account. Several different online reference sources, like Pubmed and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search brought up 115 articles, whereas the results of our search on SagePub brought up 21 articles. The results of the search conducted for the last year of 2013 yielded a total 11 articles for PubMed and 8 articles for SagePub. In the end, we compiled a total of 5 papers, 3 of which came from PubMed and 2 of which came from SagePub. We included five research that met the criteria.
Conclusion: Verapamil can be taken during pregnancy, although it is not commonly used. If patients need to take verapamil to treat high blood pressure, usually will be switched to different medicine. There are limited study and research about verapamil and its use to treat chronic hypertension in pregnancy woman.
References
NICE Guideline. Hypertension in pregnancy: diagnosis and management. National Institue for Health and Care Excellence. 2023;
Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, et al. The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study). Hypertension. 2016;68(5):1153–9.
WHO. WHO recommendations on drug treatment for non-severe hypertension in pregnancy. World Health Organization. 2020.
Rouse B, Chaimani A, Li T. Network Meta-Analysis: An Introduction for Clinicians. Intern Emerg Med. 2017;12(1):103–11.
Brown CM, Garovic VD. Drug Treatment of Hypertension in Pregnancy. Drugs [Internet]. 2014 [cited 2023 Dec 8];74(3):283–96. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558097/
Committee on Hypertension in Pregnancy. Hypertension in Pregnancy. In Washington DC: American College of Obstetricians and Gynecologists; 2013.
Seely EW, Ecker J. Chronic Hypertension in Pregnancy. Circulation AHA. 2014;129:1254–61.
Fahie S, Cassagnol M. Verapamil. StatPearls. 2023;
Ardissino M, Slob EAW, Rajasundaram S, Reddy RK, Woolf B, Girling J, et al. Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study. BMC Med. 2022 Dec 1;20(1).
Tita AT, Szychowski JM, Boggess K, Dugoff L. Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med. 2022;386:1781–92.
Bateman BT, Huybrechts KF, Maeda A, Desai R, Patorno E, Seely EW, et al. Calcium Channel Blocker
Exposure in Late Pregnancy and the Risk of Neonatal Seizures. Obstet Gynecol [Internet]. 2015 [cited 2023
Dec 8];126(2):271–8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526118/
Said NA, Badwy MA, Ghareeb AEWE, El-Rahman HAA. Study of Teratogenic Effects induced by Verapamil Administration in Pregnant Albino Rats. Int J Pharm Sci Rev Res. 2019;58(1):45–51.
UK Health Security Agency. USE OF CALCIUM CHANNEL BLOCKERS IN PREGNANCY. UKTIS. 2023.
Obstet Gynecol. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–31.
Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, et al. 2015 ACC/AHA/HRS Guideline for the
Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J AM Coll Cardiol [Internet]. 2016 [cited 2023 Dec 8];67(13):27–115. Available from:
https://pubmed.ncbi.nlm.nih.gov/26409259/
Aleyadeh W, Hutt-Centeno E, Ahmed HM, Shah NP. Hypertension guidelines: Treat patients, not numbers. Cleve Clin J Med. 2019 Jan;86(1):47–56.
Hojer J, Troutman WG, Hoppu K, Erdman A, Benson BE, Megarbane B, et al. Position paper update: ipecac syrup for gastrointestinal decontamination. Clin Toxicol (Phila). 2013;51(3):134–9.
Thanacoody R, Caravati EM, Troutman B, Hojer J, Benson B. Position paper update: whole bowel irrigation for gastrointestinal decontamination of overdose patients. Clin Toxicol. 2015;53(1):5–12.
Benson BE, Hoppu K, Troutman WG, Bedry R, Erdman A, Hojer J, et al. Position paper update: gastric lavage for gastrointestinal decontamination. Clin Toxicol [Internet]. 2013 [cited 2023 Dec 8];51(3):140–6. Available from: https://pubmed.ncbi.nlm.nih.gov/23418938/
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
